F.D.A. Rejects Closely Watched Lung Cancer Drug From China

New York Times - Nov 15, 2026

The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.

Read full article

More News

Obserworld

Delivering the latest news to the global audience with thorough research and in-depth interviews reporting on world news, latest trends, and inspirational stories.

NEWSLETTER